Liliana Raimundo

683 total citations
19 papers, 513 citations indexed

About

Liliana Raimundo is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Liliana Raimundo has authored 19 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Liliana Raimundo's work include Cancer-related Molecular Pathways (13 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Research and Treatments (3 papers). Liliana Raimundo is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Research and Treatments (3 papers). Liliana Raimundo collaborates with scholars based in Portugal, Italy and United States. Liliana Raimundo's co-authors include Lucı́lia Saraiva, Joana Soares, Helena Ramos, Joana B. Loureiro, Maria M. M. Santos, Cláudia Bessa, Sara Gomes, Miguel Leão, Célia Gomes and Daniel J. V. A. dos Santos and has published in prestigious journals such as British Journal of Pharmacology, Experimental Cell Research and Life Sciences.

In The Last Decade

Liliana Raimundo

19 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liliana Raimundo Portugal 15 316 226 91 85 36 19 513
Joana B. Loureiro Portugal 12 237 0.8× 155 0.7× 69 0.8× 46 0.5× 30 0.8× 20 413
Joana Soares Portugal 16 456 1.4× 265 1.2× 122 1.3× 153 1.8× 42 1.2× 21 713
Olivia Aranha United States 13 398 1.3× 213 0.9× 129 1.4× 76 0.9× 26 0.7× 34 676
Kathryn J. Chavez United States 5 350 1.1× 213 0.9× 68 0.7× 109 1.3× 21 0.6× 6 644
Tijana Stanković Serbia 18 386 1.2× 183 0.8× 92 1.0× 115 1.4× 15 0.4× 34 670
Chiara Palladino Italy 13 343 1.1× 113 0.5× 67 0.7× 48 0.6× 23 0.6× 19 642
Rishi K. Gara India 12 323 1.0× 98 0.4× 80 0.9× 84 1.0× 17 0.5× 12 594
Michelle Helen Visagie South Africa 15 401 1.3× 120 0.5× 110 1.2× 185 2.2× 28 0.8× 33 698
Vinod Balachandran India 12 315 1.0× 130 0.6× 48 0.5× 62 0.7× 26 0.7× 14 598
Aloran Mazumder South Korea 13 279 0.9× 96 0.4× 45 0.5× 65 0.8× 25 0.7× 25 435

Countries citing papers authored by Liliana Raimundo

Since Specialization
Citations

This map shows the geographic impact of Liliana Raimundo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liliana Raimundo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liliana Raimundo more than expected).

Fields of papers citing papers by Liliana Raimundo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liliana Raimundo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liliana Raimundo. The network helps show where Liliana Raimundo may publish in the future.

Co-authorship network of co-authors of Liliana Raimundo

This figure shows the co-authorship network connecting the top 25 collaborators of Liliana Raimundo. A scholar is included among the top collaborators of Liliana Raimundo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liliana Raimundo. Liliana Raimundo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Raimundo, Liliana, Sonia Minuzzo, Stefano Indraccolo, et al.. (2023). Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair. Cancers. 15(24). 5718–5718. 2 indexed citations
2.
Loureiro, Joana B., Liliana Raimundo, Célia Gomes, et al.. (2021). Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers. 13(7). 1648–1648. 19 indexed citations
3.
Raimundo, Liliana, et al.. (2021). Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target. Cancers. 13(14). 3438–3438. 22 indexed citations
4.
Cerqueira, Fátima, Rui Medeiros, Sara Cravo, et al.. (2021). Mechanism of Antifungal Activity by 5-Aminoimidazole-4-Carbohydrazonamide Derivatives against Candida albicans and Candida krusei. Antibiotics. 10(2). 183–183. 21 indexed citations
5.
Raimundo, Liliana, Angela Paterna, David Cardoso, et al.. (2021). BBIT20 inhibits homologous DNA repair with disruption of the BRCA1–BARD1 interaction in breast and ovarian cancer. British Journal of Pharmacology. 178(18). 3627–3647. 22 indexed citations
6.
Raimundo, Liliana, et al.. (2020). BRCA1/P53: Two strengths in cancer chemoprevention. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1873(1). 188339–188339. 16 indexed citations
7.
Ramos, Helena, Liliana Raimundo, & Lucı́lia Saraiva. (2020). p73: From the p53 shadow to a major pharmacological target in anticancer therapy. Pharmacological Research. 162. 105245–105245. 23 indexed citations
8.
Gomes, Sara, Liliana Raimundo, Joana Soares, et al.. (2019). New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma. Cancer Letters. 446. 90–102. 34 indexed citations
9.
Raimundo, Liliana, Joana Soares, Joana B. Loureiro, et al.. (2018). Improving anticancer activity towards colon cancer cells with a new p53‐activating agent. British Journal of Pharmacology. 175(20). 3947–3962. 20 indexed citations
10.
Bessa, Cláudia, Joana Soares, Liliana Raimundo, et al.. (2018). Discovery of a small-molecule protein kinase Cδ-selective activator with promising application in colon cancer therapy. Cell Death and Disease. 9(2). 23–23. 110 indexed citations
11.
Facioni, Maria Sole, Joana Soares, Sara Gomes, et al.. (2018). Biological Effects of Saponin Fractions from Astragalus verrucosus in Tumor and Non-tumor Human cells. Natural Product Communications. 13(9). 4 indexed citations
12.
Soares, Joana, Liliana Raimundo, Helena Ramos, et al.. (2017). DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties. Molecular Oncology. 11(6). 612–627. 36 indexed citations
13.
Gomes, Sara, Miguel Leão, Liliana Raimundo, et al.. (2016). p53 family interactions and yeast: together in anticancer therapy. Drug Discovery Today. 21(4). 616–624. 13 indexed citations
14.
Pereira, Daniela, Raquel T. Lima, Andreia Palmeira, et al.. (2016). Design and synthesis of new inhibitors of p53–MDM2 interaction with a chalcone scaffold. Arabian Journal of Chemistry. 12(8). 4150–4161. 22 indexed citations
15.
Leão, Miguel, Joana Soares, Sara Gomes, et al.. (2015). Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53–MDM2 interaction. Life Sciences. 142. 60–65. 28 indexed citations
16.
Soares, Joana, Liliana Raimundo, Nuno A. L. Pereira, et al.. (2015). A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins. Pharmacological Research. 95-96. 42–52. 37 indexed citations
17.
Soares, Joana, Liliana Raimundo, Nuno A. L. Pereira, et al.. (2015). Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule. Oncotarget. 7(4). 4326–4343. 37 indexed citations
18.
Leão, Miguel, Sara Gomes, Cláudia Bessa, et al.. (2014). Studying p53 family proteins in yeast: Induction of autophagic cell death and modulation by interactors and small molecules. Experimental Cell Research. 330(1). 164–177. 11 indexed citations
19.
Soares, Joana, Nuno A. L. Pereira, Miguel Leão, et al.. (2014). Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53–MDM2 interaction. European Journal of Pharmaceutical Sciences. 66. 138–147. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joana B. Loureiro Breakdown of academic impact, for papers by Joana Soares Breakdown of academic impact, for papers by Olivia Aranha Breakdown of academic impact, for papers by Kathryn J. Chavez Breakdown of academic impact, for papers by Tijana Stanković Breakdown of academic impact, for papers by Chiara Palladino Breakdown of academic impact, for papers by Rishi K. Gara Breakdown of academic impact, for papers by Michelle Helen Visagie Breakdown of academic impact, for papers by Vinod Balachandran Breakdown of academic impact, for papers by Aloran Mazumder
Rankless by CCL
2026